LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE

313 reported adverse events

Drug classes: Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

These side effects are most commonly reported by patients taking LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE:

# Side effect Count
0 FOETAL EXPOSURE DURING PREGNANCY 12
1 MATERNAL EXPOSURE DURING PREGNANCY 10
2 ABORTION SPONTANEOUS 6
3 ANHEDONIA 5
4 ANXIETY 5
5 EMOTIONAL DISTRESS 5
6 PAIN 5
7 PREMATURE BABY 4
8 DEPRESSION 3
9 EXPOSURE DURING PREGNANCY 3
See all common reactions for LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE

LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LATENT SYPHILIS 1 0.0435
1 BENIGN ENLARGEMENT OF THE SUBARACHNOID SPACES 1 0.0370
2 ASCARIASIS 1 0.0303
3 OPHTHALMIA NEONATORUM 1 0.0263
4 GENITAL PROLAPSE 1 0.0179
5 SUBCHORIONIC HAEMATOMA 3 0.0170
6 BLASTOCYSTIS INFECTION 1 0.0115
7 BIRTH MARK 2 0.0096
8 CONGENITAL SKIN DIMPLES 2 0.0083
9 DANDY-WALKER SYNDROME 2 0.0077
See all enriched reactions for LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE